Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Every 3 months during maintenance: fasting metabolic panel, PHQ-9, menstrual cycle regularity assessment, body composition review (waist circumference or DXA at 12 months), medication reconciliation
Intermittent claudication in peripheral arterial disease In peripheral arterial disease, atherosclerosis of the arteries that supply the lower extremities may diminish blood flow to the point that the metabolic needs of exercising muscles are not sufficiently met, thereby leading to ischemic leg or hip pain known as claudication (see the page on Intermittent Claudication in Peripheral Arterial Disease) (63)
It is not indicated : In patients with normal weight or overweight without comorbidities
Summary Bottom line: Early human studies suggest GLP-1 drugs (e.g., semaglutide/Ozempic/Wegovy and tirzepatide/Mounjaro/Zepbound) can reduce alcohol cravings and sometimes heavy drinkingbut none are FDA-approved for Alcohol Use Disorder (AUD) yet
US$ 21.09
US$ 27.35
US$ 28.99
US$ 20.94
US$ 29.40
US$ 23.95
